Ipsen: appointment of an independent director
This appointment will be effective for the remainder of Paul Sekhri's term of office, until the 2026 AGM. Pascal Touchon will be a member of the Appointments Committee, the Innovation and Development Committee and the Audit Committee.
Currently CEO of Atara Biotherapeutics, Pascal Touchon has previously held several management positions at Novartis and Servier, and has also served on the boards of various biotech companies.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction